Why I'm Selling Moderna into the Relief Rally
I'm trimming my Moderna position despite recent gains. Valuation concerns, slowing vaccine revenue, rising competition and few near-term catalysts make the rally fragile.
Seeking Alpha
2 min read
Stocks
Market Analysis
Healthcare